MINI FUTURE LONG - PFIZER INC | Market Closed - Euronext Paris 17:30:01 03/05/2024 BST | ||
| 8.12 EUR | -3.10% |
|
| Current month | +26.16% | ||
| 1 month | +0.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/05/24 | 8.15 | -2.74% | 37 |
| 02/05/24 | 8.38 | +29.72% | 42 |
| 30/04/24 | 6.46 | +0.31% | 40 |
| 29/04/24 | 6.44 | +3.37% | 45 |
| 26/04/24 | 6.23 | -1.27% | 43 |
Real-time Euronext Paris
Last update May 03, 2024 at 05:30 pm
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| EF85B | |
| ISIN | NL0011425921 |
| Date issued | 31/08/2015 |
| Strike | 20.28 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 36.72 € |
|---|---|
| Lowest since issue | 3.37 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.81
USD
Average target price
31.89
USD
Spread / Average Target
+14.68%
- Stock Market
- Certificates
- EF85B Certificat
